Medicare Enrolled

Dr. Raghav Govindarajan, MD

Neurology · O Fallon, IL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
3 SAINT ELIZABETH BLVD, O Fallon, IL 62269
6186415803
In practice since 2010 (16 years)
NPI: 1639481914 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Govindarajan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Govindarajan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Govindarajan

Dr. Raghav Govindarajan is a neurology specialist in O Fallon, IL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Govindarajan performed 36,966 Medicare services across 1,775 unique beneficiaries.

Between the years covered by Open Payments, Dr. Govindarajan received a total of $695,543 from 34 pharmaceutical and/or device companies across 828 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Govindarajan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 1% volume in IL $695,543 industry payments

Medicare Practice Summary

Medicare Utilization ↗
36,966
Medicare services
Top 1% in IL for neurology
1,775
Unique beneficiaries
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,310 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Botox injection, per unit
An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered.
34,620 $5 $26
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
367 $66 $158
Electromyography of arm or leg muscles
A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them.
284 $75 $175
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
237 $121 $321
Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle 185 $58 $135
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
172 $1 $7
Chemical nerve block injection, 5+ arm/leg muscles
Injection of a chemical agent to paralyze five or more muscles in the first extremity treated.
144 $132 $555
Chemical nerve paralysis injection, each additional extremity
Injection of a chemical agent to paralyze nerves and muscles in an additional arm or leg. This is billed for each extremity beyond the first one treated.
122 $100 $394
EEG brain wave test, 61-119 minutes
This procedure measures electrical activity in the brain using electrodes placed on the scalp. It records brain wave patterns for a duration between 61 and 119 minutes.
116 $65 $781
Nerve conduction studies, 7-8 tests
A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles.
111 $130 $376
Nerve conduction studies, 13 or more
A diagnostic test that measures how well nerves send electrical signals. This code applies when 13 or more individual nerve studies are performed.
110 $220 $569
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
106 $93 $228
Awake and drowsy EEG
A test that records electrical activity in the brain while the patient is awake and drowsy.
81 $44 $636
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
57 $131 $440
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
47 $106 $265
Limited ultrasound of joint or extremity
A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels.
46 $28 $124
Chemical nerve block for neck muscles
Injection of a chemical agent to paralyze specific muscles on the side of the neck, excluding the voice box.
45 $171 $437
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
43 $42 $203
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
28 $67 $198
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
17 $129 $320
Nerve conduction studies, 11-12
A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies.
16 $183 $508
New patient office visit, complex (60-74 min) 12 $151 $398
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$695,543
Total received (2018-2024)
Avg $99,363/year across 7 years
Top 1% in IL for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
828
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$606,970 (87.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$87,116 (12.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,457 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$149,709
2023
$161,667
2022
$92,985
2021
$114,198
2020
$58,038
2019
$80,548
2018
$38,400

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ARGENX US, INC.
$47,948
UCB, Inc.
$25,994
Takeda Pharmaceuticals U.S.A., Inc.
$23,101
ABBVIE INC.
$22,309
Alexion Pharmaceuticals, Inc.
$14,283
Amgen Inc.
$12,101
Johnson & Johnson Health Care Systems Inc.
$2,725
Janssen Scientific Affairs, LLC
$1,000
PFIZER INC.
$248
Top 3 companies account for 64.8% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$243,325
ARGENX US, INC.
$115,233
Biohaven Pharmaceuticals, Inc.
$66,505
UCB, Inc.
$64,159
ABBVIE INC.
$52,039
Takeda Pharmaceuticals U.S.A., Inc.
$34,462
Biohaven Pharmaceutical Holding Company Ltd.
$28,955
Janssen Scientific Affairs, LLC
$20,795
Mitsubishi Tanabe Pharma America, Inc.
$15,284
Amgen Inc.
$12,101
F. Hoffmann-La Roche AG
$9,534
Janssen Global Services, LLC
$9,474
MITSUBISHI TANABE PHARMA AMERICA, INC.
$8,688
Sarepta Therapeutics, Inc.
$2,960
Johnson & Johnson Health Care Systems Inc.
$2,725
Biogen, Inc.
$1,850
AbbVie Inc.
$1,731
Amicus Therapeutics, Inc.
$1,600
Akcea Therapeutics, Inc.
$1,540
CATALYST PHARMACEUTICALS, INC.
$1,228
PFIZER INC.
$450
GENZYME CORPORATION
$159
CSL Behring
$122
Allergan, Inc.
$115
AbbVie, Inc.
$106
Medtronic USA, Inc.
$80
Medtronic, Inc.
$63
Novartis Gene Therapies, Inc. (fka AveXis, Inc.)
$60
Sunovion Pharmaceuticals Inc.
$49
Genentech, Inc.
$48
Novartis Pharmaceuticals Corporation
$33
E.R. Squibb & Sons, L.L.C.
$30
Merz Pharmaceuticals, LLC
$25
Baxter Healthcare
$14
Top 3 companies account for 61.1% of all-time payments
Associated products mentioned in payments ›
ACTIVA · APTIOM · AUBAGIO · BOTOX · COMIRNATY · DUOPA · Duopa · ENSPRYNG · EXSERVAN · Enspryng · Evrysdi · FIRDAPSE · HYQVIA · Hillrom - Synclara Cough System · Hizentra · INTELLIS · KESIMPTA · LINQ II · MAYZENT · NURTEC ODT · Non-Covered Product · OCTAGAM IMMUNE GLOBULIN (HUMAN) · PANZYGA · PAXLOVID · QULIPTA · RADICAVA · Radicava · Rystiggo · SOLIRIS · Soliris · TEGSEDI · UBRELVY · ULTOMIRIS · UPLIZNA · Ultomiris · VYVGART · VYVGART HYTRULO · Xeomin · ZEPOSIA · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (87%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for neurology in IL.

Looking for a neurology specialist in O Fallon?
Compare neurologists in the O Fallon area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
223
Per 100K population
87.5
County median income
$70,178
Nearest hospital
HSHS ST ELIZABETH'S HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Govindarajan is a mixed practice specialist, with above-average Medicare volume (top 1% in IL), with speaking/promotional industry engagement in the top 1% of IL peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Govindarajan experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Govindarajan performed 34,620 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Govindarajan receive payments from pharmaceutical companies?
Yes. Dr. Govindarajan received a total of $695,543 from 34 companies across 828 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Govindarajan's costs compare to other neurologists in O Fallon?
Dr. Govindarajan's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Govindarajan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →